drugset / Trial / NCT01642238
Antithrombotic Effects of Ticagrelor Versus Clopidogrel
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether treatment with ticagrelor (plus aspirin and bivalirudin) is more effective than treatment with clopidogrel (plus aspirin and bivalirudin).
Timeline
- Start
- 2012-07
- Primary completion
- 2013-03
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 600 mg | — |
| Subject | Ticagrelor | Small molecule | 180 mg | — |
| Comparator | Aspirin | Small molecule | 81 mg | — |
| Comparator | Bivalirudin | Peptide | 1.75 mg/kg | Intravenous |